outsourcing is one of the success factors of
the company, according to the CEO: “While
everyone was decentralizing, outsourcing, we
vertically grew our production and today we do
a lot internally, such as engineering, packaging
material, bioequivalence studies, transmission and
distribution,” he explains.
Prati-Donaduzzi invests constantly and
increasingly in infrastructure, job training,
research and development to expand its product
line. All the machinery is from the biggest and
best global centers of manufacturing equipment
in the pharmaceutical industry, such as Italy, USA,
Japan, England and Germany.
The future, in the present
With projected earnings over US$ 250 million
for this year, Prati-Donaduzzi innovates once
again. The company deployed a drug presentation
template unexplored by large companies in the
sector in Brazil, the fractional drug, which can be
Medicines
page 471
September 2012
